activins has been researched along with Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fjodorova, M; Li, M | 1 |
| Arber, C; Cambray, S; Dunnett, SB; Fjodorova, M; Heuer, A; Kelly, C; Li, M; Noakes, Z; Precious, SV; Risner-Janiczek, JR; RodrÃguez, TA; Rosser, AE; Ungless, MA | 1 |
| Alexi, T; Clark, RG; Gluckman, PD; Hughes, PE; Williams, CE | 1 |
3 other study(ies) available for activins and Huntington Disease
| Article | Year |
|---|---|
Robust Induction of DARPP32-Expressing GABAergic Striatal Neurons from Human Pluripotent Stem Cells.
Topics: Activins; Cell Culture Techniques; Cell Differentiation; Cell- and Tissue-Based Therapy; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; GABAergic Neurons; Human Embryonic Stem Cells; Humans; Huntington Disease; Induced Pluripotent Stem Cells | 2018 |
Activin A directs striatal projection neuron differentiation of human pluripotent stem cells.
Topics: Activins; Animals; Cell Differentiation; Cell Line; Cell Survival; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Embryonic Stem Cells; GABAergic Neurons; Ganglia; Hedgehog Proteins; Humans; Huntington Disease; Neostriatum; Neurons; Pluripotent Stem Cells; Rats; Repressor Proteins; Signal Transduction; Tumor Suppressor Proteins | 2015 |
Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Topics: Activins; Animals; Calbindin 2; Choline O-Acetyltransferase; Corpus Striatum; gamma-Aminobutyric Acid; Humans; Huntington Disease; Inhibins; Interneurons; Male; Nerve Growth Factors; Neurons; Phenotype; Quinolinic Acid; Rats; Rats, Wistar; Recombinant Proteins; S100 Calcium Binding Protein G; Synaptic Transmission | 1999 |